# CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy

Article · Daniel Rosenblum, Anna Gutkin, Ranit Kedmi, Srinivas Ramishetti, Nuphar Veiga, Ashley M. Jacobi, Mollie S. Schubert, Dinorah Friedmann‐Morvinski, Zvi R. Cohen, Mark A. Behlke, Judy Lieberman, Dan Peer

- Archive id: doi:10.1126/sciadv.abc9450
- Published: 2020-11-19
- Venue: Science Advances
- DOI: https://doi.org/10.1126/sciadv.abc9450
- PMID: 33208369
- Citations: 613
- Source URL: https://doi.org/10.1126/sciadv.abc9450
- PDF: https://advances.sciencemag.org/content/advances/6/47/eabc9450.full.pdf
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [CRISPR & Gene-Editing Therapies](https://space-kitty.com/topics/gene-editing-therapies)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.